MedTrace Logo

Pain Measured by NRS and EEG in Acute Pulpitis

NCT06526572 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-07-31

No results posted yet for this study

Summary

The aim of the proposed study is to investigate and comprehensively understand pain perception in patients diagnosed with symptomatic acute pulpitis who are resistant to inferior alveolar nerve block (IANB).

The study aims to achieve this by utilizing a dual approach that combines subjective self-reporting of pain intensity using the Numeric Rating Scale (NRS) with objective neurophysiological assessment through brain wave analysis using electroencephalography (EEG).

By integrating these two methods, the study seeks to explore potential correlations between self-reported pain scores and neural responses recorded through EEG, providing insights into the pain experience of this specific patient population.

Ultimately, the goal of the study is to enhance the understanding of pain perception mechanisms in individuals with symptomatic acute pulpitis resistant to IANB and potentially guide the development of more effective and personalized pain management strategies for these patients.

Conditions

  • Acute Pulpitis

Interventions

DIAGNOSTIC_TEST

Brain wave analysis using electroencephalography (EEG).

Asessment of pain with objective neurophysiological assessment through brain wave analysis using electroencephalography (EEG).

DIAGNOSTIC_TEST

Numerical rate Scale (NRS)

Asessment of pain with the subjective numercal rate scale method (NRS

Sponsors & Collaborators

  • Cleveland Dental Institute

    lead OTHER

Principal Investigators

  • Ahmed A hashem, PhD · CDI

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-10-31
Completion
2025-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06526572 on ClinicalTrials.gov